本页面由Tiger Trade Technology Pte. Ltd.提供服务

Alpha Tau Medical

7.82
-0.6000-7.13%
成交量:25.08万
成交额:201.08万
市值:6.67亿
市盈率:-14.98
高:8.39
开:8.35
低:7.70
收:8.42
52周最高:8.60
52周最低:2.30
股本:8,526.41万
流通股本:5,713.21万
量比:0.98
换手率:0.44%
股息:- -
股息率:- -
每股收益(TTM):-0.5219
每股收益(LYR):-0.4540
净资产收益率:-54.38%
总资产收益率:-25.56%
市净率:8.59
市盈率(LYR):-17.22

数据加载中...

2026/02/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/30

SEC问询函

Form CORRESP - Correspondence
2025/03/12

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/12

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/03/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/07

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/07

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/12/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/20

SEC问询函

Form CORRESP - Correspondence
2023/06/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities